Insufficient scRNA-seq data for expression of B3GALT6 at single-cell level.
Insufficient scRNA-seq data for expression of B3GALT6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 864.37 | 328 / 328 | 100% | 32.56 | 178 / 178 |
thymus | 100% | 1110.56 | 653 / 653 | 100% | 41.92 | 605 / 605 |
uterus | 100% | 1256.81 | 170 / 170 | 100% | 46.75 | 459 / 459 |
brain | 100% | 1132.44 | 2636 / 2642 | 100% | 40.91 | 705 / 705 |
esophagus | 100% | 826.12 | 1439 / 1445 | 100% | 29.77 | 183 / 183 |
breast | 100% | 1163.68 | 459 / 459 | 99% | 40.04 | 1111 / 1118 |
skin | 100% | 1376.37 | 1809 / 1809 | 99% | 39.87 | 469 / 472 |
intestine | 100% | 842.56 | 966 / 966 | 99% | 31.15 | 523 / 527 |
prostate | 100% | 1107.86 | 245 / 245 | 99% | 51.14 | 498 / 502 |
stomach | 99% | 799.23 | 356 / 359 | 100% | 28.23 | 286 / 286 |
liver | 100% | 940.42 | 226 / 226 | 99% | 22.27 | 402 / 406 |
ovary | 99% | 893.18 | 178 / 180 | 100% | 45.59 | 430 / 430 |
bladder | 100% | 997.62 | 21 / 21 | 99% | 36.88 | 498 / 504 |
kidney | 100% | 977.30 | 89 / 89 | 98% | 24.58 | 885 / 901 |
adrenal gland | 100% | 1092.69 | 258 / 258 | 98% | 25.94 | 225 / 230 |
lung | 98% | 967.57 | 567 / 578 | 100% | 30.32 | 1151 / 1155 |
adipose | 100% | 1081.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 31.04 | 29 / 29 |
spleen | 100% | 1341.91 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 41.96 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 59.20 | 1 / 1 |
heart | 100% | 776.15 | 857 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 858.94 | 1328 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 719.71 | 795 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 34.02 | 79 / 80 |
peripheral blood | 79% | 502.66 | 736 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030203 | Biological process | glycosaminoglycan metabolic process |
GO_0015012 | Biological process | heparan sulfate proteoglycan biosynthetic process |
GO_0030166 | Biological process | proteoglycan biosynthetic process |
GO_0030206 | Biological process | chondroitin sulfate biosynthetic process |
GO_0006024 | Biological process | glycosaminoglycan biosynthetic process |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0000139 | Cellular component | Golgi membrane |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016020 | Cellular component | membrane |
GO_0005797 | Cellular component | Golgi medial cisterna |
GO_0047220 | Molecular function | galactosylxylosylprotein 3-beta-galactosyltransferase activity |
GO_0035250 | Molecular function | UDP-galactosyltransferase activity |
Gene name | B3GALT6 |
Protein name | Beta-1,3-galactosyltransferase 6 (Beta-1,3-GalTase 6) (Beta3Gal-T6) (Beta3GalT6) (EC 2.4.1.134) (GAG GalTII) (Galactosyltransferase II) (Galactosylxylosylprotein 3-beta-galactosyltransferase) (UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6) Hexosyltransferase (EC 2.4.1.-) |
Synonyms | |
Description | FUNCTION: Beta-1,3-galactosyltransferase that transfers galactose from UDP-galactose to substrates with a terminal beta-linked galactose residue. Has a preference for galactose-beta-1,4-xylose that is found in the linker region of glycosaminoglycans, such as heparan sulfate and chondroitin sulfate. Has no activity towards substrates with terminal glucosamine or galactosamine residues. . |
Accessions | Q499Z2 Q96L58 ENST00000379198.5 |